Immunofluorescence analysis revealed increased IFN-γ-expressing CD8+ T cells in the combined treatment group, compared with tumors treated with either H101 or PD-1 blockade alone, confirming the enhanced anti-tumor response exerted by IFN-γ-expressing CD8+ T cells. The gene discussed is PDCD1; the disease is neoplasm.